314. Brian Le Gette, Founder & CEO of Ammortal

Today, I'm joined by Brian Le Gette, founder & CEO of Ammortal.

 

A wellness technology company, Ammortal's immersive recovery chambers combine PEMF, red light, molecular hydrogen, breathwork, and meditation into a single therapeutic experience.

 

In this episode, we discuss building the future of regenerative wellness tech.

 

We also cover:

• Raising a Series A and scaling commercially

• Developing the product, pricing model, and partnerships

• Stacking cellular repair modalities with mind-body integration

 

Subscribe to the podcast → insider.fitt.co/podcast  

Subscribe to our newsletter → insider.fitt.co/subscribe  

Follow us on LinkedIn → linkedin.com/company/fittinsider 

 

Website: www.ammortal.com 

Locations: www.ammortal.com/locations 

Commercial Inquiries: [email protected]  

Partnerships: [email protected]

Instagram: https://www.instagram.com/ammortal_official

Facebook: https://www.facebook.com/ammortals 

 

-

 

The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com to learn more about its smart fitness ecosystem for fitness and health facilities.

 

Fitt Talent: https://talent.fitt.co

Consulting: https://consulting.fitt.co 

Investments: https://capital.fitt.co

 

Chapters: 

(00:00) Introduction

(01:20) Brian's background and entrepreneurial journey

(02:40) What is Ammortal and the one-of-one category

(02:55) The core modality stack and protocol design

(05:10) Origin story

(06:30) Positioning beyond wellness buzzwords

(09:00) Why "tech doesn't heal—it aids self-healing"

(11:30) Target customer: optimization-focused consumers

(14:30) Distribution strategy

(18:00) Pricing models and commercial partnerships

(21:15) The experience design and musical cocoon concept

(23:30) Education and onboarding for new users

(25:30) Customer outcomes and use case versatility

(27:35) Landing on "chamber" as the product descriptor

(29:05) Long-term vision and R&D philosophy

(31:15) The collaborative model for wellness innovation

(32:45) Raising a Series A and scaling commercially

(34:10) Conclusion